MedTrace Logo

A Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

NCT06668142 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2026-03-23

No results posted yet for this study

Summary

Robotic assisted surgery for benign prostatic hyperplasia (BPH)

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DEVICE

Beacon Platform

The Beacon Platform is a robotically assisted surgical (RAS) device. It enables the urologist, through software, to control and move surgical instruments for a variety of transurethral, endoscopic procedures

Sponsors & Collaborators

  • Andromeda Surgical

    lead INDUSTRY

Principal Investigators

  • Peter Gilling, MD, FRACS · Tauranga urology research

  • Rodrigo Ledezma, MD, · University of Chile Clinical Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-12
Primary Completion
2026-12-30
Completion
2026-12-30

Countries

  • Chile
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06668142 on ClinicalTrials.gov